ORCID as entered in ROS
https://orcid.org/0000-0001-5042-3632
Select Publications
Conference Papers
, 2018, 'Radium 223 Therapy in Symptomatic Metastatic Castrate Resistant Prostate Cancer - Newcastle Experience: a Quality of Life Issue', in CLINICAL ONCOLOGY, ELSEVIER SCIENCE LONDON, pp. 194 - 194
, 2017, 'A systematic review and critical evaluation of reported sequence variants in hidradenitis suppurativa/acne inversa using ACMG standards and guidelines', in AUSTRALASIAN JOURNAL OF DERMATOLOGY, WILEY, pp. 56 - 56, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000423998100165&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2017, 'Drug induced hidradenitis suppurativa / acne inversa: A systematic review of case reports with insights into pathogenesis of disease', in AUSTRALASIAN JOURNAL OF DERMATOLOGY, WILEY, pp. 13 - 13, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000423998100036&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2017, 'Intertriginous planar xanthoma secondary to dyslipidaemia in an infant', in AUSTRALASIAN JOURNAL OF DERMATOLOGY, WILEY, pp. 104 - 104, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000423998100302&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2017, 'Systematic review of neonatal cutaneous langerhan cell histiocytosis and metaanlysis of risk of progression to systemic disease', in AUSTRALASIAN JOURNAL OF DERMATOLOGY, WILEY, pp. 59 - 59, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000423998100175&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2017, 'Concentrations of synthetic pyrethroids in surface water and sediment from agricultural and urban land use areas', in ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, AMER CHEMICAL SOC, CA, San Francisco, presented at
, 2017, 'Examination of the relative contributions of aqueous and dietary uptake to pyrethroid accumulation in organisms at different aquatic trophic levels', in ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, AMER CHEMICAL SOC, CA, San Francisco, presented at
, 2017, 'Why are real-world surface water exposure distributions much lower than US EPA FIFRA Tier II EECs? An evaluation based on pyrethroid insecticides', in ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, AMER CHEMICAL SOC, CA, San Francisco, presented at
, 2016, 'Analysis of monitoring data for synthetic pyrethroids in US surface water and sediment', in ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, AMER CHEMICAL SOC
, 2016, 'Toxicokinetics of imidacloprid in rainbow trout', in ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, AMER CHEMICAL SOC
, 2015, 'Long-term oncological outcomes of patients undergoing neoadjuvant chemotherapy and cystectomy for muscle invasive bladder cancer', in BJU INTERNATIONAL, WILEY-BLACKWELL, ENGLAND, Manchester, pp. 75 - 75, presented at
, 2015, 'Review of the proposed pathogenic mechanisms underlying rosacea and possible clinical implications of vascular and inflammatory involvement', in AUSTRALASIAN JOURNAL OF DERMATOLOGY, WILEY-BLACKWELL, pp. 28 - 28, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000352562300078&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2015, 'Outcome of Radium-223 in metastatic castrate resistant prostate cancer: an audit to assess real life experience at the Northern Centre for Cancer Care, Newcastle-upon-Tyne.', in CLINICAL ONCOLOGY, ELSEVIER SCIENCE LONDON, pp. S5 - S5, http://dx.doi.org/10.1016/j.clon.2015.04.020
, 2014, 'Issues surrounding topical corticosteroid use amongst dermatology patients in NSW public hospitals: A qualitative analysis and development of a topical corticosteroid patient identification chart', in AUSTRALASIAN JOURNAL OF DERMATOLOGY, WILEY-BLACKWELL, pp. 57 - 58, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000335981400187&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2014, 'Longitudinal analysis of psoriasis severity, metabolic syndrome and quality of life in patients on biologic therapy', in AUSTRALASIAN JOURNAL OF DERMATOLOGY, WILEY-BLACKWELL, pp. 18 - 18, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000335981400060&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2013, 'Multinucleate cell angiohistiocytoma: Presentation and pathological processes: A systematic review of 119 reports and eight new cases', in AUSTRALASIAN JOURNAL OF DERMATOLOGY, WILEY-BLACKWELL, pp. 7 - 7, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000324328600023&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2013, 'Neoadjuvant chemotherapy or cystectomy for muscle-invasive bladder cancer - an analysis of survival outcomes at a UK tertiary referral centre', in BJU INTERNATIONAL, WILEY-BLACKWELL, ENGLAND, Manchester, pp. 70 - 70, presented at
, 2013, 'The development and validation of the TABQOL, a tool to measure the quality of life impacts of treatments used in patients with autoimmune blistering disease', in JOURNAL OF INVESTIGATIVE DERMATOLOGY, NATURE PUBLISHING GROUP, SCOTLAND, Edinburgh, pp. S37 - S37, presented at
, 2013, 'Translocation of the cytokine HMGB1 coincides with wound healing in fibroblast-injected wounds of recessive dystrophic epidermolysis bullosa', in JOURNAL OF INVESTIGATIVE DERMATOLOGY, NATURE PUBLISHING GROUP, SCOTLAND, Edinburgh, pp. S137 - S137, presented at
, 2013, 'Common causes with uncommon presentations: HSV2-mediated cutaneous ulceration in the setting of Wegener's granulomatosis', in AUSTRALASIAN JOURNAL OF DERMATOLOGY, WILEY-BLACKWELL, pp. 39 - 39, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000319131900179&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2013, 'The clinical significance of drug interactions between dermatological and psychoactive medications', in AUSTRALASIAN JOURNAL OF DERMATOLOGY, WILEY-BLACKWELL, pp. 14 - 14, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000319131900044&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2012, 'DARWINIAN DERMATOLOGY: THE CONTRIBUTION OF HAIR LOSS AND CONSTITUTIVE PIGMENTATION TO THE PATHOGENESIS OF PSORIASIS VULGARIS AND ACNE VULGARIS', in WOUND REPAIR AND REGENERATION, WILEY-BLACKWELL, pp. A71 - A71, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000308945000076&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2012, 'Improving clinical application of quality of life scores in epidermolysis bullosa (EB): Clinical significant outcomes in the QOLEB questionnaire', in Australasian Journal of Dermatology, New South Wales : Wiley-Blackwell, Australia, pp. 38 - 38, presented at
, 2012, 'IS CONCOMITANT CARCINOMA IN SITU A RELATIVE CONTRAINDICATION TO NEOADJUVANT CHEMOTHERAPY FOR MUSCLE INVASIVE TCC BLADDER?', in JOURNAL OF UROLOGY, LIPPINCOTT WILLIAMS & WILKINS, GA, Atlanta, pp. E576 - E576, presented at
, 2011, 'A randomised controlled trial assessing the effectiveness of minigrafting versus ReCell in stable vitiligo: preliminary results', in Ronai Z (ed.), Pigment Cell & Melanoma Research, Blackwell Munksgaard, England, pp. 834 - 835, presented at
, 2011, 'Development of a disease-specific quality of life instrument for autoimmune bullous dermatoses: the ABQOL', in JOURNAL OF INVESTIGATIVE DERMATOLOGY, NATURE PUBLISHING GROUP, SPAIN, Barcelona, pp. S33 - S33, presented at
, 2011, 'Methodologies in translating patient based measures in dermatology: International validation of the quality of life in epidermolysis bullosa (QOLEB) questionnaire', in Australasian Journal of Dermatology, New South Wales : Wiley-Blackwell, Australia, pp. 25 - 26, presented at
, 2011, 'Quality of life outcomes of cultured allogeneic fibroblast therapy recipients with epidermolysis bullosa', in Australasian Journal of Dermatology, New South Wales : Wiley-Blackwell, Australia, pp. 26 - 26, presented at
, 2011, 'Final Results of Vortigern Study: CT Versus Pet-CT Based Tomotherapy Voluming and Dose Escalation in Oropharyngeal Squamous Cell Carcinoma (ISRCTN 33175361, UKCRN ID: 08/h0907/127)', in CLINICAL ONCOLOGY, ELSEVIER SCIENCE LONDON, pp. S26 - S26, http://dx.doi.org/10.1016/j.clon.2011.01.386
, 2011, 'IS SAFE DOSE ESCALATION POSSIBLE IN OROPHARNGEAL SCC: RESULTS OF THE VORTIGERN STUDY', in RADIOTHERAPY AND ONCOLOGY, ELSEVIER IRELAND LTD, pp. S327 - S327, http://dx.doi.org/10.1016/S0167-8140(11)70965-3
, 2010, 'RCT of intradermal allogeneic fibroblast therapy for generalized severe recessive dystrophic epidermolysis bullosa randomized against placebo injections', in AUSTRALASIAN JOURNAL OF DERMATOLOGY, WILEY-BLACKWELL PUBLISHING, INC, pp. A7 - A8, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000284242800038&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2010, 'First double-blind randomized clinical trial of intradermal allogeneic fibroblast therapy for severe generalized recessive dystrophic epidermolysis bullosa randomized against placebo injections resulted in similar wound healing that is independent of collagen VII expression', in JOURNAL OF INVESTIGATIVE DERMATOLOGY, NATURE PUBLISHING GROUP, FINLAND, Helsinki, pp. S67 - S67, presented at
, 2010, 'Vortig ERN: Variation of radiotherapy target volume definintion, dose to organs at risk (OAR), and clinical target volumes using anatomic (CT)versus combined anatomic and molecular imaging (PET-CT): Intensity-modulated radiotherpay delivered using a tomotherapy hi art machine', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, http://dx.doi.org/10.1200/jco.2010.28.15_suppl.tps267
, 2010, 'Prognostic significance of different alpha 6 beta 4 integrin immunolabelling patterns at the dermal-epidermal junction in epidermolysis bullosa associated with pyloric atresia', in AUSTRALASIAN JOURNAL OF DERMATOLOGY, WILEY, pp. A27 - A27, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000435023300085&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2010, 'Quantum mechanics in dermatology: The biophysics of electrosurgery', in AUSTRALASIAN JOURNAL OF DERMATOLOGY, WILEY, pp. A27 - A27, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000435023300086&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2010, 'OPTIMISING DOSE TO THE MUSCLES OF MASTICATION (MOM)- A COMPARATIVE DOSIMETRIC AND RADIOBIOLOGICAL ANALYSIS OF TREATMENT PLANS IN TREATING ADVANCED HEAD AND NECK CARCINOMA.: 'HELICAL TOMOTHERAPY'(HT) VERSUS 'FORWARD PLANNED IMRT'(FIMRT) VERSUS '2 PHASE PHOTON ELECTRON JUCNCTION TECHNIQUE'(JNTECH)', in RADIOTHERAPY AND ONCOLOGY, ELSEVIER IRELAND LTD, pp. S324 - S324
, 2009, 'How to organize a ski and adventure camp for young patients with severe forms of epidermolysis bullosa', in Proceedings of the 3rd Asia International Conference on Modelling and Simulation (AMS 2009) Asia Modelling Symposium 2009, IEEE Computer Society Conference Publishing Services (CPS), pp. 13-18, Los Alamitos, CA, US, pp. AB5 - AB5, -
, 2009, 'Investigation of cell therapy for generalized severe recessive dystrophic epidermolysis bullosa by intradermal allogeneic fibroblasts randomized against placebo injections', in Journal of Investigative Dermatology, Nature Publishing Group, United States, pp. S28 - S28, -
, 2008, 'Prognostic significance of different alpha 6 beta 4 Integrin immunolabelling patterns at the dermal-epidermal junction in epidermolysis bullosa associated with pyloric atresia', in JOURNAL OF INVESTIGATIVE DERMATOLOGY, NATURE PUBLISHING GROUP, AUSTRALIA, Sydney, pp. 2917 - 2917, presented at
, 2008, 'Quality of life evaluation in epidermolysis bullosa: development and results of the QOLEB questionnaire', in JOURNAL OF INVESTIGATIVE DERMATOLOGY, NATURE PUBLISHING GROUP, AUSTRALIA, Sydney, pp. 2911 - 2911, presented at
, 2008, 'Reactivity of LH7.2 and FNC1 antibodies against collagen VII does not predict the development of squamous cell carcinomas in recessive dystrophic epidermolysis bullosa', in Journal of Investigative Dermatology, Nature Publishing Group, United States, pp. S27 - S27, presented at
Conference Presentations
, 2015, 'Phenotypic variations in hidradenitis suppurativa imply heterogeneous pathogenic pathways with potential adjuvant therapeutic targets'
Conference Abstracts
, 2022, 'Spatial transcriptomic analysis of HS skin lesions reveals that tunnels are immunologically active and activity correlates with disease severity', in JOURNAL OF INVESTIGATIVE DERMATOLOGY, ELSEVIER SCIENCE INC, Vol. 142, pp. S143 - S143, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000829693001376&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2022, 'Real-world disease characteristics and treatment patterns amongst patients with atopic dermatitis in Australia: The Atopic Dermatitis Patient Satisfaction and Unmet Need Survey', in AUSTRALASIAN JOURNAL OF DERMATOLOGY, WILEY, Vol. 63, pp. 61 - 61, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000788396100154&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2022, 'The association between elevated Malassezia specific IgE levels and the development of worsening head/neck dermatitis after Dupilumab commencement', in AUSTRALASIAN JOURNAL OF DERMATOLOGY, WILEY, Vol. 63, pp. 5 - 5, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000788396100024&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2022, 'Hidradenitis suppurativa in Australia', in EXPERIMENTAL DERMATOLOGY, WILEY, ELECTR NETWORK, Vol. 31, pp. 62 - 62, presented at 11th European-Hidradenitis-Suppurativa-Foundation-e-V (EHSF) Conference, ELECTR NETWORK, 09 February 2022 - 11 February 2022, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000849696800050&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2021, 'Down syndrome in hidradenitis suppurativa: a systematic review of 4893 patients', in EXPERIMENTAL DERMATOLOGY, WILEY, ELECTR NETWORK, Vol. 30, pp. 57 - 57, presented at 10th Scientific Conference of the European-Hidradenitis-Suppurativa-e-V (EHSF), ELECTR NETWORK, 10 February 2021 - 12 February 2021
, 2021, 'Comorbidities of hidradenitis suppurativa: Interpretation and clinical Implications', in EXPERIMENTAL DERMATOLOGY, WILEY, Vol. 30, pp. 32 - 33
, 2020, 'Epithelialized tracts are active mediators of inflammation in hidradenitis suppurativa', in JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, MOSBY-ELSEVIER, ELECTR NETWORK, Vol. 83, pp. AB24 - AB24, presented at Meeting of the American-Academy-of-Dermatology (AAD), ELECTR NETWORK, 12 June 2020 - 14 June 2020, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000598634300096&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2020, 'In silico analysis of gamma-secretase complex mutations in hidradenitis suppurativa demonstrates disease-specific substrate recognition and cleavage alterations', in JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, MOSBY-ELSEVIER, ELECTR NETWORK, Vol. 83, pp. AB49 - AB49, presented at Meeting of the American-Academy-of-Dermatology (AAD), ELECTR NETWORK, 12 June 2020 - 14 June 2020, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000598634300197&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
Filter by type
https://orcid.org/0000-0001-5042-3632